Almitas Capital
$417M 13F equity value
150 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Almitas Capital covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| FBTC | FIDELITY WISE ORIGIN BITCOIN | 1,364,522 | $70M | 16.7% |
| BTT | BLACKROCK MUN TARGET TERM TR | 1,485,213 | $34M | 8.1% |
| ASA | ASA GOLD AND PRECIOUS MTLS L | 629,121 | $33M | 7.8% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 974,881 | $18M | 4.2% |
| DSGN | DESIGN THERAPEUTICS INC | 1,026,893 | $15M | 3.6% |
| PDX | PIMCO DYNAMIC INCOME STRATEG | 549,495 | $11M | 2.7% |
| CRF | CORNERSTONE TOTAL RETURN FD | 1,572,309 | $11M | 2.7% |
| CNNE | CANNAE HLDGS INC | 741,318 | $11M | 2.6% |
| MEGI | NYLI CBRE GBL INFR MEGTRNDS | 557,462 | $8M | 2.0% |
| LYEL | LYELL IMMUNOPHARMA INC | 581,407 | $8M | 2.0% |
Track Almitas Capital's 13F portfolio: $417M in reported holdings, 150 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}